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Obesity in women of reproductive age has deleterious effects on reproductive and offspring
health. In this study, we aimed to evaluate the association between the magnitude of peri-
conceptional body-mass index (BMI) change and maternal and neonatal outcomes in obese
infertile women who participated in the LIFEstyle study. The LIFEstyle study was a random-
ized controlled trial, evaluating if a six-month lifestyle intervention program prior to infertility
treatment in obese infertile women improved birth rates, compared to prompt infertility
treatment.
Methods and findings
This is an exploratory post hoc analysis of the LIFEstyle study. We recorded periconcep-
tional BMI change in women with an ongoing pregnancy, pooling data of all women,
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regardless of randomization arm. Periconceptional BMI change was calculated using
weight at randomization and the periconceptional weight (measured in kilograms 12
weeks before or after conception and expressed as BMI change in units BMI (kg/m2)).
Subsequently, women were categorized into quartiles according to the magnitude of their
periconceptional change in BMI. The odds of maternal and neonatal outcomes were cal-
culated using logistic regression analysis, comparing women in each of the first three
weight change quartiles separately, and combined, to women in the fourth quartile. The
fourth quartile was chosen as reference group, since these women had the least weight
loss. We adjusted for periconceptional BMI, nulliparity and smoking status. In addition,
we performed a subgroup analysis for singleton pregnancies. In the LIFEstyle study, 321
obese infertile women achieved an ongoing pregnancy which was conceived within 24
months after randomization. Periconceptional BMI change was available in 244 of these
women (76%). Median BMI at randomization was 35.9 kg/m2. Women in the first quartile
(Q1) had a periconceptional BMI change of <-2.1 kg/m2, women in the second quartile
(Q2) -2.1 to -0.9 kg/m2, women in the third quartile (Q3) -0.9 to 0.1 kg/m2 and women in
the fourth quartile (Q4) gained 0.1 kg/m2. There were no significant differences between
women in the quartiles regarding rates of excessive gestational weight gain (in term preg-
nancies), gestational diabetes, preterm birth, induction of labor, spontaneous vaginal
birth and Caesarean section. Compared to women in Q4, the adjusted odds ratios, aOR,
and 95% confidence interval for a hypertensive complication were; 0.55 (0.22–1.42) for
women in Q1, 0.30 (0.12–0.78) for women in Q2, 0.39 (0.16–0.96) for women in Q3 and
0.39 (0.19–0.82) for women in Q1 to Q3 combined. In the subgroup analysis, investigating
singleton pregnancies only, the statistically significant decreased rate of a hypertensive
complication remained in women in Q2 (aOR 0.27, 95% CI 0.10–0.72) and Q3 (aOR 0.39,
95%CI 0.16–0.98) and when comparing women in Q1 to Q3 together to women in Q4
(aOR 0.38, 95%CI 0.18–0.80). Furthermore, there was a significantly decreased aOR
(95%CI) of preterm birth in women in Q2 (0.24, 0.06–0.98) and when combining women
in Q1 to Q3 (0.37, 0.14–0.97) compared to women in Q4.
Conclusions
These results suggest that a periconceptional decrease in BMI in obese infertile women
could lead to a decrease of the rates of hypertensive pregnancy complications and preterm
birth. The results are limited by the exploratory nature of the analyses and further evidence
is necessary to provide more definitive conclusions.
Introduction
Obesity, defined as a body-mass index (BMI)30kg/m2, has deleterious effects on women’s
reproductive health and health of their offspring [1–4]. Obese women are at an increased risk
of adverse pregnancy outcomes, such as gestational hypertension, preeclampsia and gestational
diabetes [5,6]. Moreover, there is an increased risk of induction of labor, shoulder dystocia,
postpartum hemorrhage and Caesarean section [5,7,8]. Maternal obesity is also associated
with an increased risk of adverse neonatal outcomes, including an increased rate of preterm
birth, large-for-gestational age (LGA) infants, neonatal intensive care unit (NICU) admission,
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congenital anomalies and perinatal death [9–12]. Furthermore, children born from obese
mothers have an increased risk of childhood and adulthood overweight or obesity and
increased mortality rate later in life [3,13–15].
Studies investigating the effect of antenatal lifestyle interventions to prevent excessive gesta-
tional weight gain and/or obesity-associated complications in overweight and obese pregnant
women report limited clinical risk reduction of maternal and perinatal complications [16–20].
Preconceptional interventions might have a greater impact on the reduction of obesity-associ-
ated complications during pregnancy and in offspring, as is exemplified by studies on the
effects of preconceptional bariatric surgery [21,22]. Even though rates of macrosomia and
large-for-gestational age (LGA) are generally decreased after bariatric surgery, rates of small-
for-gestational age (SGA) are increased [22,23].
We conducted a randomized controlled trial (RCT), in which we investigated reproductive
outcomes in obese infertile women who were randomized to a six-month lifestyle intervention
program preceding infertility treatment, as compared to prompt infertility treatment [24]. The
lifestyle intervention did not result in higher rates of the primary outcome, the vaginal births
of a healthy singleton at term within 24 months after randomization, while it did result in com-
parable rates of ongoing pregnancies and more natural conceptions in the intervention group
[25]. Rates of maternal and neonatal complications were not different between randomization
groups, but the influence of the magnitude of weight loss on these outcomes was not analyzed
separately.
Only few studies have been performed regarding the association between periconceptional
weight loss and maternal and neonatal outcomes in obese women [26]. It is not known
whether a periconceptional decrease in BMI improves pregnancy outcomes in women who
did not receive bariatric surgery and what amount of weight loss could do so. Therefore, the
purpose of the current analysis is to investigate whether periconceptional weight loss influ-
ences maternal and neonatal pregnancy outcomes and to determine what amount of weight
loss could affect these outcomes.
Materials and methods
We used data from the LIFEstyle study, a multicenter RCT. The study protocol and results of
the LIFEstyle study have been reported previously [24,25]. The study protocol of the LIFEstyle
study was approved by the Medical Ethics Committee (MEC; 2008.284) of the University Med-
ical Centre Groningen and the board of directors of each participating center. The study was
conducted in adherence to the Declaration of Helsinki and all participants gave written
informed consent. In short, obese infertile women were randomly allocated to a lifestyle inter-
vention program preceding infertility treatment (intervention group) or to prompt infertility
treatment (control group). Women in the intervention group received a six-month lifestyle
intervention, which consisted of an energy-restricted diet, an increase of physical activity and
motivational counseling. The lifestyle intervention was aimed at 5–10% weight loss and the
program included six outpatient visits and four telephone consultations. After completion of
the six-month lifestyle intervention, women could commence with infertility treatment if they
had not conceived naturally during the intervention period. Women in the control group
started infertility treatment promptly after randomization. Infertility treatment in both study
arms could consist of expectant management, ovulation induction, intrauterine insemination,
in vitro fertilization or intracytoplasmic sperm injection including transfers of frozen embryos,
depending on the diagnosis. The indicated type of treatment was based on guidelines from the
Dutch Society of Obstetrics and Gynecologists [27]. Women were followed for 24 months
after randomization. Data on the course of pregnancy and childbirth was also recorded when a
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woman conceived within 24 months after randomization but childbirth occurred after the 24
months of follow-up. The primary outcome of the LIFEstyle study was the vaginal birth of a
healthy singleton at term within 24 months after randomization. A power calculation was per-
formed using the primary outcome of the study [24]. A total of 63 women (21.8%) discontin-
ued the lifestyle intervention. The mean weight loss at 6 months after randomization was 4.4kg
in 236 non-pregnant women in the intervention group and 1.1 kg in 128 non-pregnant
women in the control group (P<0.001)[25].
Periconceptional weight change
For the current analysis we used pooled data, regardless of randomization arm, of women who
had an ongoing pregnancy and complete follow-up during the LIFEstyle study. By doing so,
we aimed to investigate the association between pregnancy outcomes and periconceptional
change in BMI, irrespective of its cause, be it participation in the intervention or possibly a
personal initiative to change diet after receiving the information of the deleterious effects of
overweight as part of the patient information provided at the start of the study. Furthermore,
this is an exploratory post-hoc analysis, which was not described in the study protocol prior to
the start of the LIFEstyle study.
Women with an ongoing pregnancy that was conceived within 24 months after randomiza-
tion, for whom data on periconceptional weight was available, were categorized into quartiles
according to their change in BMI units (kg/m2). We used change in BMI since this accurately
reflects change in body composition for women with different statures. We calculated weight
change using weight at randomization and the periconceptional weight. Periconceptional
weight was determined using the weight at the first antenatal visit (which for infertile couples
is usually at 7 to 8 weeks gestation). When this was not available the self-measured weight at 12
weeks gestation or weight within 12 weeks of conception was used. To provide a clinical more
meaningful outcome, women were also categorized in quartiles using periconceptional weight
change in kilograms and the analyses were repeated.
Maternal and neonatal outcomes
Maternal and neonatal outcomes were recorded for all ongoing pregnancies conceived within
24 months after randomization. Maternal adverse outcomes were: excessive gestational weight
gain (>9 kilograms for women with BMI >30 kg/m2 or >11.5 kilograms for women with BMI
25–29.9kg/m2 in a term pregnancy) [28], gestational diabetes (any form of hyperglycemia dur-
ing pregnancy) [29], hypertensive complications (pregnancy-induced hypertension [a systolic
blood pressure of 140 mmHg and/or diastolic blood pressure of 90 mmHg at 20 weeks
gestation, measured at two occasions], preeclampsia [pregnancy-induced hypertension with
proteinuria of at least 300mg per 24 hours] and HELLP syndrome [characterized by hemolysis,
elevated liver-enzyme levels, and a low platelet count]) [30]. In addition, we recorded preterm
birth (<37 weeks gestational age), induction of labor (induction of labor by artificial means)
and mode of delivery (spontaneous vaginal birth, assisted vaginal birth or Caesarean section).
Gestational weight gain was assessed using self-measured weight during pregnancy. Gesta-
tional weight gain records were considered complete when weight was measured from four
weeks before parturition until the delivery in a term pregnancy and when the periconceptional
BMI and weight in kilograms was known.
Neonatal outcomes were SGA or LGA (defined as birth weight below the 10th or above the
90th percentile according to the Dutch reference curves) [31]. Due to low prevalence of the
individual complications a composite neonatal outcome was used, consisting of cord pH
<7.05, Apgar score<7 at 5 minutes, admission to the NICU and perinatal death (stillbirth
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above 24 weeks gestation or early neonatal death within six weeks postpartum) [12]. For neo-
natal outcomes, the number of women was the denominator.
Statistical analysis
Descriptive statistics are given as n, %, median and interquartile range (IQR) where appropri-
ate. Baseline characteristics in the weight change quartiles were compared using the non-
parametric Kruskall-Wallis test for continuous variables and the chi-square test for categorical
variables.
The probabilities of maternal and neonatal outcomes were calculated as a function of
weight change. For each outcome, we performed logistic regression analysis, comparing
women in each of the first three weight change quartiles separately, and combined (women in
Q1, Q2 and Q3 grouped together), to women in the fourth quartile. The fourth quartile was
chosen as reference group, since these women had the least weight loss. P-values for linear rela-
tion of the aOR across the BMI change quartiles were calculated (using the quartiles as a con-
tinuous variable). We adjusted for periconceptional BMI, nulliparity and smoking status in the
logistic regression analyses. Adjusted odds ratios (aOR) and 95% confidence intervals (CI) are
presented. Since pregnancy of multiples affect maternal and neonatal outcomes, we repeated
the analyses in singleton pregnancies. Randomization arm in the randomized controlled trial
could be a potential confounder in the analysis, therefore logistic regression analyses with ran-
domization group (intervention or control group), BMI change quartile and the interaction
term between randomization group and quartile were performed without adjustment for con-
founders. A significant interaction between the BMI change quartiles and the lifestyle inter-
vention was defined as a p-value <0.1.
All analyses were performed using Statistical Package for the Social Sciences Statistics, ver-
sion 22 (IBM Corporation, Armonk, USA). Statistical significance was assumed with a p<0.05
(except for the analysis investigating statistical interaction).
Results
The flowchart of the analysis is shown in Fig 1. Of all 577 women who were randomized and
provided informed consent, 290 women were allocated to the lifestyle intervention program
preceding infertility treatment (intervention group) and 287 to prompt infertility treatment
(control group). Ten women in the intervention group and three women in the control group
had incomplete follow-up or withdrawal of informed consent. Of all women in the interven-
tion and control group combined, 321 women conceived within 24 months after randomiza-
tion and had an ongoing pregnancy. For 244 (76%) of these women the periconceptional
weight change was available.
Median BMI at study entry was 36.0 kg/m2 (IQR 4.7 kg/m2). Median periconceptional BMI
change in the 244 women was -0.9 kg/m2 (IQR -2.1 to 0.1 kg/m2). Women in the first quartile
(Q1) had a periconceptional BMI change of<-2.1 kg/m2, women in the second quartile (Q2)
-2.1 to -0.9 kg/m2, women in the third quartile (Q3) -0.9 to 0.1 kg/m2 and women in the fourth
quartile (Q4) gained0.1 kg/m2. Median weight at study entry was 103.8 kg (IQR 15.4 kg).
Median periconceptional weight change in kilograms was -2.6 kg (IQR 6.5kg). Baseline charac-
teristics are summarized in Table 1. Women who achieved most weight loss were more often
randomized to the intervention group (p<0.01) and had a longer time to pregnancy (p<0.01).
Women with a missing periconceptional weight had a significantly longer time to pregnancy
compared to women with known periconceptional weight (p<0.01).
Periconceptional weight loss in obese infertile women
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Maternal outcomes
There were no significant differences between quartile groups regarding rates of excessive ges-
tational weight gain, gestational diabetes, preterm birth, induction of labor, spontaneous vagi-
nal birth, assisted vaginal birth and Caesarean section (Table 2).
A hypertensive complication occurred in 23% of women in Q1 (aOR 0.55, 95%CI 0.22–
1.42), in 15% of women in Q2 (aOR 0.30, 95%CI 0.12–0.78), in 16% of women in Q3 (aOR
0.39, 95%CI 0.16–0.96) and 34% of women in Q4 (reference). When women in quartiles 1 to 3
were combined and compared to women in Q4 there was an aOR of 0.39 (95%CI 0.19–0.82) of
having a hypertensive complication during pregnancy.
Maternal outcomes according to periconceptional weight change in kilograms are shown in
S1 Table. Results were similar to the analysis using periconceptional change in BMI, except for
the difference between hypertensive complications in women in Q3 compared to women in
Q4, which was not significantly different (aOR 0.42, 95% CI 0.18–1.03).
Fig 1. Flowchart of the analysis.
https://doi.org/10.1371/journal.pone.0192670.g001
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Neonatal outcomes
There were no significant differences in the rates of SGA, LGA or the composite adverse neo-
natal outcome among women within the BMI change quartiles (Table 3).
Table 1. Baseline characteristics of women according to weight change quartile.
BMI change quartiles All women included in the
analysis
Women with missing


















0.44 29.3 (6.6) 27.9 (6.1)






0.27 36.0 (4.7) 35.9 (5.1)
Blood pressure
– Systolic mmHg 122 (18) 125 (13) 122 (18) 124 (18) 0.74 125 (19) 129 (19)
– Diastolic mmHg 80 (10) 80 (10) 80 (6) 80 (15) 0.96 80 (10) 80 (15)
Maternal smoking N 12 (20) 10 (16) 11 (18) 13 (21) 0.87 46 (19) 22 (29)
Ethnic origin 0.93
– Caucasian n 55 (90) 54 (89) 55 (90) 53 (87) 217 (89) 68 (88)
– Other n 6 (10) 7 (12) 6 (10) 8 (13) 27 (11) 9 (12)
Education 0.20
– Primary school n 2 (3.3) 1 (1.6) 3 (4.9) 2 (3.3) 8 (3.3) 2 (2.6)
– Secondary education n 10 (16) 10 (16) 13 (21) 14 (23) 47 (19) 21 (27)
– Intermediate vocational
education
n 26 (43) 27 (44) 33 (54) 33 (54) 119 (49) 33 (43)
– Higher vocational education and
university
n 21 (34) 19 (31) 11 (18) 7 (12) 58 (24) 17 (22)
– Unknown n 2 (3.3) 4 (6.6) 1 (1.6) 5 (8.2) 12 (4.9) 4 (5.2)
Randomized to lifestyle intervention n 38 (62) 35 (57) 19 (31) 21 (34) <0.01 113 (46) 41 (53)
Duration of infertility months 21 (23) 17 (13) 19 (14) 19 (23) 0.23 19 (17) 16 (14)
Nulliparous n 46 (75) 50 (82) 43 (71) 49 (80) 0.43 188 (77) 66 (86)
Time to pregnancy from
randomization
months 7.8 (4.5) 4.4 (7.8) 3.3 (6.6) 5.2 (7.7) <0.01 6.0 (7.1) 11 (10)a




– first antenatal visit n 41 (67) 40 (66) 37 (61) 44 (72) 162 (66) NA
– self-reported 12 weeks after
gestation
n 11 (18) 13 (21) 9 (15) 14 (23) 47 (19) NA
– measured within 12 weeks of
conception
n 9 (15) 8 (13) 15 (25) 3 (4.9) 35 (14) NA
Table shows number of women (%) or median (IQR) by quartiles of BMI change between randomization in the LIFEstyle study and the periconceptional period. Unless
otherwise stated, baseline characteristics were measured at randomization. Medians were compared using the Kruskal-Wallis test and for categorical data using the Chi-
square test.
a Women with a missing periconceptional weight change had a significantly longer time to pregnancy, p<0.01 and more often a multiple pregnancy, p = 0.01.BMI,
body-mass index NA, not applicable
Although periconceptional weight change in the intervention (-4.1 kg, IQR 7.2 kg) and control group (-1.0 kg, IQR 5.5 kg) was significantly different (p<0.001), there
was a considerable overlap in periconceptional weight change (Fig 2).
https://doi.org/10.1371/journal.pone.0192670.t001
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In addition, there were no significant differences in the rates of SGA, LGA or the composite
adverse neonatal outcome among women within the weight change quartiles in kilograms (S2
Table).
Subgroup analysis of singleton pregnancies
The results of the subgroup analysis on maternal and neonatal outcomes according to pericon-
ceptional change in BMI in singleton pregnancies are shown in S3 and S4 Tables. In this sub-
group analysis, the significantly decreased rate of a hypertensive complication remained in
women in Q2 (aOR 0.27, 95% CI 0.10–0.72) and Q3 (aOR 0.39, 95%CI 0.16–0.98) and when
comparing women within Q1, Q2 and Q3 grouped together to women in Q4 (aOR 0.38, 95%
Fig 2. Periconceptional weight change in the intervention and control group.
https://doi.org/10.1371/journal.pone.0192670.g002
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CI 0.18–0.80). In addition, there was a significantly decreased rate of preterm birth in women
in Q2 (aOR 0.24, 95% CI 0.06–0.98) compared to women in Q4 and when comparing women
in Q1, Q2 and Q3 grouped together to women in Q4 (aOR 0.37, 95%CI 0.14–0.97). There
were no significant differences in rates of excessive gestational weight gain in term pregnan-
cies, gestational diabetes, induction of labor, spontaneous vaginal birth, assisted vaginal birth
and Caesarean section between quartiles. The rates of LGA or SGA and the composite neona-
tal outcome were not different between quartiles.
Table 2. Maternal outcomes by quartile of BMI change.
Quartile Q1 Q2 Q3 Q4
ΔBMI <-2.1 -2.1 to -0.9 -0.9 to 0.1 >0.1 aOR Q1to 3 vs Q4a P-value linear relation
Rates of ongoing pregnancies within 24 months
n = 61b n = 61 n = 61 n = 61
Maternal outcomes
Excessive gestational weight gainc rate (%) 21/34 (62) 20/30 (67) 10/26 (39) 14/27 (52)
aOR 1.71 2.06 0.61 1.00 1.17 0.15
(95%CI) (0.51–5.76) (0.59–7.13) (0.19–1.99) (0.43–3.24)
Gestational diabetes rate (%) 8 (13) 8 (13) 15 (25) 10 (16)
aOR 0.93 0.93 1.69 1.00 1.24 0.61
(95%CI) (0.29–2.95) (0.31–2.74) (0.65–4.40) (0.52–2.99)
Hypertensive complications rate (%) 14 (23) 9 (15) 10 (16) 21 (34)
aOR 0.55 0.30 0.39 1.00 0.39 0.17
(95%CI) (0.22–1.42) (0.12–0.78) (0.16–0.96) (0.19–0.82)
Rates of live births conceived within 24 months
n = 59 n = 60 n = 61 n = 60
Preterm birth rate (%) 10 (17) 4 (6.7) 5 (8.2) 12 (20)
aOR 0.88 0.30 0.37 1.00 0.46 0.75
(95%CI) (0.30–2.64) (0.09–1.04) (0.12–1.19) (0.19–1.11)
Induction of labor rate (%) 25 (42) 20 (33) 25 (41) 30 (50)
aOR 0.92 0.59 0.76 1.00 0.73 0.71
(95%CI) (0.40–2.10) (0.27–1.28) (0.36–1.61) (0.38–1.39)
Spontaneous vaginal birth rate (%) 33 (56) 44 (73) 36 (59) 33 (55)
aOR 0.76 1.91 0.95 1.00 1.15 0.94
(95%CI) (0.33–1.75) (0.85–4.29) (0.45–2.04) (0.59–2.21)
Assisted vaginal birthd rate (%) 7 (18) 6 (12) 12 (25) 8 (20)
aOR 1.41 0.69 1.88 1.00 1.04 0.85
(95%CI) (0.38–5.22) (0.20–2.33) (0.63–5.58) (0.69–1.56)
Caesarean section rate (%) 19 (32) 10 (17) 13 (21) 19 (32)
aOR 1.15 0.46 0.63 1.00 0.67 0.89
(95%CI) (0.47–2.81) (0.19–1.16) (0.27–1.48) (0.33–1.36)
Table shows rates and % of maternal outcomes by quartiles of BMI change. Odds ratios are adjusted for periconceptional BMI, nulliparity and smoking. P-values for the
linear relation of quartiles of BMI change were calculated using the quartiles as a continuous variable, with adjustment for confounders.
a Women in Q1, Q2 and Q3 were grouped together in the analysis and compared to women in Q4
b One woman with an ongoing pregnancy had no follow-up during pregnancy and outcomes were not recorded
c In term pregnancies only
d The denominator is the total number of vaginal births
BMI, body-mass index, aOR, adjusted odds ratio, CI, confidence interval
https://doi.org/10.1371/journal.pone.0192670.t002
Periconceptional weight loss in obese infertile women
PLOS ONE | https://doi.org/10.1371/journal.pone.0192670 March 28, 2018 9 / 16
Effect modification of randomization group
The logistic regression analyses with addition of an interaction term for randomization group
and the BMI change quartile did not show any statistically significant modification of the effect
of BMI change by randomization group.
Discussion
In this exploratory post-hoc analysis of pooled data of both treatment groups of the LIFEstyle
RCT, we investigated the association between the magnitude of periconceptional BMI and
weight change in quartiles and maternal and neonatal outcomes in obese infertile women. Our
results show that women with a periconceptional BMI change between -2.1 and 0.1 kg/m2 (Q2
and Q3), had a decreased rate of hypertensive pregnancy complications compared to women
who gained0.1 kg/m2 during the periconceptional period. In addition, when women in Q1,
Q2 and Q3 were grouped together and compared to women in Q4 there was an aOR of 0.39
(95%CI 0.19–0.82) of having a hypertensive complication during pregnancy. This was appar-
ent in the total group and in the subgroup analysis including women with a singleton preg-
nancy. For women with a singleton pregnancy, the rate of preterm birth was significantly
decreased in women who lost -2.1 to -0.9 kg/m2 (Q2) during the periconceptional period and
when women in Q1, Q2 and Q3 were grouped together compared to women in Q4. There
were no differences in rates of excessive gestational weight gain, gestational diabetes, induction
Table 3. Neonatal outcomes by quartile of BMI change.
Quartile Q1 Q2 Q3 Q4
ΔBMI <-2.1 -2.1 to -0.9 -0.9 to 0.1 >0.1 aOR Q1 to3 vs Q4a P-value linear relation
n = 61b n = 61 n = 61 n = 61
Maternal outcomes
SGAc rate (%) 6 (10) 2 (3.3) 4 (6.6) 4 (6.7)
aOR 1.32 0.41 0.91 1.00 0.80 0.87
(95%CI) (0.27–6.44) (0.07–2.56) (0.20–4.13) (0.21–3.03)
LGAc rate (%) 8 (14) 10 (17) 10 (16) 9 (15)
aOR 1.31 1.49 1.42 1.00 1.42 0.66
(95%CI) (0.41–4.19) (0.52–4.27) (0.51–3.99) (0.58–3.50)
Composite neonatal outcome rate (%) 8 (13) 5 (8.2) 4 (6.6) 10 (16)
aOR 0.63 0.39 0.34 1.00 0.42 0.51
(95%CI) (0.19–2.08) (0.11–1.33) (0.10–1.20) (0.16–1.12)
Abnormal cord pH rate (%) 1/40 (2.5) 1/35 (2.9) 1/37 (2.7) 1/39 (2.6)
Apgar < 7 rate (%) 4 (6.7) 2 (3.3) 1 (1.6) 2 (3.3)
Admission to NICU rate (%) 4 (6.7) 3 (4.9) 3 (4.9) 9 (15)
Perinatal death rate (%) 1 (1.7) 2 (3.3) 0 1 (1.6)
Table shows rates and % of neonatal outcomes by quartiles of BMI change. Odds ratios are adjusted for periconceptional BMI, nulliparity and smoking. Composite
neonatal outcome consisted of an abnormal cord pH (<7.05), Apgar <7 at 5 minutes, admission to the NICU and perinatal death (stillbirth above 24 weeks gestation or
early neonatal death within six weeks postpartum). P-values for the linear relation of quartiles of BMI change were calculated using the quartiles as a continuous
variable, with adjustment for confounders.
a Women in Q1, Q2 and Q3 were grouped together in the analysis and compared to women in Q4
b One woman with an ongoing pregnancy had no follow-up during pregnancy and outcomes were not recorded
c The denominator is the number of live births (Q1 n = 59, Q2 n = 59, Q3 n = 62 and Q4 n = 61)
BMI, body-mass index, SGA, small-for-gestational age, aOR, adjusted odds ratio, CI, confidence interval, LGA, large-for-gestational age, NICU, neonatal intensive care
unit
https://doi.org/10.1371/journal.pone.0192670.t003
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of labor, mode of birth, small for gestational age or large for gestational age and the composite
neonatal outcome among women in the different weight change quartiles.
Interestingly, women with the most periconceptional BMI and weight loss in kilograms (in
Q1) did not have a significantly decreased risk of a hypertensive complication or preterm birth
(in the subgroup analysis), while women in Q2 and/or Q3 periconceptional weight loss did
have a significantly decreased risk of these complications. The point estimates of the adjusted
odds ratios are well below 1 for all the BMI change quartiles, suggesting that the risk of these
complications is lower after weight loss. The fact that this does not reach significance in all
quartiles could be the consequence of the relatively small numbers of outcomes in these quar-
tiles, which make the point estimates more susceptible to chance fluctuation. It is also possible
that periconceptional BMI and weight loss (as seen in Q2 and Q3) instead of more substantial
weight loss (as seen in Q1) is more favorable for decreasing complications, but there is no evi-
dence supporting this hypothesis. The discrepancy in the incidence of preterm births between
the main analysis and subgroup analysis can be explained by the higher risk of preterm birth
usually present in multiple pregnancies [32].
A large body of evidence exists on the negative impact of increased maternal BMI on repro-
ductive, maternal and neonatal outcomes. However, studies on the effects of lifestyle interven-
tions to decrease periconceptional weight to possibly counteract the adverse effects of
overweight are limited. This might be due to difficulties providing interventions for women
who are planning a pregnancy, as they are generally healthy and have minimal engagement to
the healthcare system. Furthermore, most studies focus on interpregnancy weight loss. Villa-
mor and Cnattingius did not find a significant difference in the rate of gestational hyperten-
sion or gestational diabetes in overweight women who lost >1 kg/m2 before the next
pregnancy, but there was a lower rate of LGA [26]. This was also observed by Jain et al., who
found that obese women with an interpregnancy weight loss of2 kg/m2 had an aOR 0.61
(95%CI 0.52–0.73) of having an LGA neonate [33]. We did not observe a decreased rate of
LGA in obese women who achieved periconceptional weight loss. However, the rate of LGA
was relatively low in our study. Our results are in agreement with findings of Mostello et al.,
who found that women who decreased their BMI between pregnancies were less likely to expe-
rience recurrent preeclampsia [34].
An explanation of the limited effects of lifestyle intervention on pregnancy outcomes in
this study could be the limited amount of weight change that can be achieved through a life-
style intervention. Studies that were performed to investigate the effects of preconception
bariatric surgery, which usually results in a larger weight change, have shown it to be associ-
ated with decreased rates of gestational diabetes, hypertensive disorders, fetal macrosomia
and LGA [21–23]. However, the risk of SGA is increased and some studies report a shorter
duration of gestation [22,23]. Average weight loss that can be achieved by obese women of
reproductive age after bariatric surgery is on average minus 8 to 15 kg/m2 [22]. This is
much greater than weight loss that can be achieved with a lifestyle intervention with a dura-
tion of six months, as in our study. However, remarkably, the magnitude of effect in reduc-
tion of the rate of hypertensive disorders is comparable to that in our study. A biological
explanation for this effect may lie in a reduction in low-grade inflammation after weight
loss [34,35]. Obesity is associated with an increase in oxidative stress and inflammatory
markers [36–38], as is seen in preeclampsia [39]. Weight loss is associated with improve-
ment of this low-grade inflammation [35] and the decreased risk of hypertensive disorders
could therefore be mediated through a decreased inflammatory state associated with weight
loss [34].
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Strengths and limitations
The main strength of this study is that we used data from the largest prospective study so far
on the effect of a preconception lifestyle intervention program targeted at weight loss in obese
infertile women. By taking into account women all women who had an ongoing pregnancy in
the LIFEstyle study we could create a large and unique cohort with prospectively collected
periconceptional data on weight change and a subsequent pregnancy. In addition, due to the
prospective data collection inherent to the RCT design of the LIFEstyle study, we were able to
adjust for important confounders. While previous studies investigated relations between inter-
pregnancy weight change and maternal or neonatal outcomes, our study provides a unique
perspective, in which 77% of women are nulliparous.
A limitation of the current analysis is that the LIFEstyle study was powered on the healthy
live birth rate within 24 months, instead of on adverse maternal and neonatal outcomes. Nev-
ertheless, we were able to demonstrate some statistically significant associations between peri-
conceptional weight loss and maternal outcomes. Secondly, since the cohort data we analyzed
originate from a randomized controlled trial of a lifestyle intervention, effects of periconcep-
tional weight loss on pregnancy outcomes could be confounded by effects of the lifestyle inter-
vention other than weight loss. We found no evidence of such effects or of interaction between
periconceptional weight change and treatment group. Even with these results confounding of
the pregnancy outcomes by the lifestyle intervention cannot entirely be excluded and should
be kept in mind when interpreting the results of this analysis. Finally, we were not able to con-
trol for all possible mediators of outcomes of pregnancy and/or periconceptional weight loss.
Our results show that 56% of women gained excessive amounts of weight during pregnancy.
Since only 54% of women with an ongoing pregnancy in our study provided the self-measured
data of their weight change during pregnancy, we could not adjust our analyses for this factor.
Excessive gestational weight gain is associated with an increased rate of various maternal and
neonatal complications [40] and therefore could possibly mask the association between peri-
conceptional weight change and outcomes of pregnancy. Currently, recording gestational
weight gain and measures to prevent excessive gestational weight gain are not part of routine
obstetric care in The Netherlands. We recommend that gestational weight gain should be
recorded to facilitate research on outcomes of pregnancy in obese women. In addition, the
amount of weight change an infertile woman can achieve before conception might be influ-
enced by undergoing infertility treatment. Women who participated in the LIFEstyle study
underwent different types of infertility treatment, therefore we could not construct reliable
adjustments for this factor.
These data provide an insight into the possible magnitude of effect of periconceptional weight
loss on perinatal outcomes. For the rare outcomes, especially in the neonate, combining our data
with similar trials in an individual participant data meta-analysis could provide a more definite
answer to the question whether periconceptional weight loss has a beneficial effect on maternal
and neonatal outcomes in obese (infertile) women. Our estimates may be imprecise due to resid-
ual confounding, but their magnitude is clinically relevant and warrants further study.
Conclusions
These results suggest that a periconceptional decrease in BMI in obese infertile women could
lead to a decrease in the rate of a hypertensive pregnancy complication and preterm birth. Our
study was not powered on adverse pregnancy outcomes and therefore these results should be
seen as explorative, indicating the magnitude of effect on maternal and neonatal outcomes
that can be achieved by a preconception weight loss program. However their magnitude is
clinically relevant and warrants further study.
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